Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 03, 2021

SELL
$42.92 - $53.03 $9.8 Million - $12.1 Million
-228,275 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$36.16 - $47.63 $291,268 - $383,659
-8,055 Reduced 3.41%
228,275 $10.1 Million
Q4 2020

Jan 19, 2021

BUY
$32.69 - $37.69 $3.26 Million - $3.75 Million
99,597 Added 72.84%
236,330 $8.24 Million
Q3 2020

Oct 20, 2020

SELL
$34.54 - $40.79 $510,501 - $602,876
-14,780 Reduced 9.75%
136,733 $4.98 Million
Q2 2020

Jul 30, 2020

BUY
$36.63 - $44.07 $79,413 - $95,543
2,168 Added 1.45%
151,513 $5.69 Million
Q1 2020

Apr 17, 2020

SELL
$29.5 - $45.96 $1.03 Million - $1.6 Million
-34,813 Reduced 18.9%
149,345 $5.48 Million
Q4 2019

Jan 16, 2020

BUY
$33.75 - $41.12 $6.22 Million - $7.57 Million
184,158 New
184,158 $7.46 Million

Others Institutions Holding PBH

About Prestige Consumer Healthcare Inc.


  • Ticker PBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,762,600
  • Market Cap $3.91B
  • Description
  • Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...
More about PBH
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.